Sanofi-Aventis announced recently the results of a study that demonstrated that patients using Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals reported improved patient reported outcomes and decreased glycemic variability versus patients treated with premix analog insulin.

» Continue Reading

Related terms:

• glargine glulisine
• davidson glulisine
• Glulisine Glargine
• glulisine to glargine
• insulin glargine rdna origin ppt
• Glargine 2012
• insuline glargine glulisine
• davidson glargine
• davidson 2011 glargine and glulisine
• Davidson glargine glulisine powerpoint
• what is the IU conversion for insuline glulisine
• DIFFERENCE OF INSULIN GLARGINE TO INSULIN GLULISINE
• basal-bolus apidra
• glargine combination glulisine
• basal bolus quality of life
• Glargine glulisine Davidson 2011
• Apidra pregnancy 2012 ppt
• glargine ppt
• glargine switching to premix
• ano ang insuline